According to a 2016 study, the mean price of insulin increased nearly 3-fold between 2002 and 2013.
Overweight and obesity are established risk factors for the development of metabolic diseases, including diabetes, hypertension, dyslipidemia, and cardiovascular disease.
The transition from pediatric to adult care for type 1 diabetes should be a gradual process, with a plan to make the change when the patient is ready, not at a pre-determined time.
Guidelines from The Endocrine Society, updated in 2017, advocate a shared decision-making approach regarding growth hormone therapy and advise against routine treatment for all children with idiopathic short stature.
Comorbid depression, when not well controlled, can affect one's ability to self-manage diabetes. There can be loss of interest in making proper lifestyle choices, monitoring glucose levels, and taking one's medicines.
Findings suggest that insulin resistance and deficiency may increase the risk of Alzheimer disease via their influence on brain function.
Divergent recommendations in guidelines from the USPSTF and the ATA/AACE contribute to the controversy surrounding whether to test and treat for subclinical hypothyroidism.
Current oral contraceptive products contain lower doses of estrogen than those used in the past, prompting reconsideration of risks and benefits.
Environmental causes of T2D and other metabolic disorders are often overlooked; a new body of evidence, however, is changing the clinical thinking about mitigating these effects on those at high risk of T2D.
Obesity has a substantial effect on general health parameters, but its role in rheumatoid arthritis is much more complex.
Insulin resistance contributes to the increased risk of type 2 diabetes in individuals with polycystic ovary syndrome.
Although metformin has been studied in randomized trials as adjunctive therapy to insulin in individuals with type 1 diabetes, further investigation in the form of outcomes trials is necessary to assess risks vs benefits.
Ranking or otherwise gauging physician quality isn't just a way to assign bragging rights — performance metrics can be used to set reimbursement levels, tailor insurance, and identify physicians who are falling behind.
Dr Bush discusses the combination of SGLT2 inhibitors and GLP-1 receptor agonist for the treatment of type 2 diabetes.
Endocrinologist Kevin M. Pantalone, DO, and psychiatrist Christian Kohler, MD, discuss the risk associated with the use of antipsychotic medications in individuals with type 2 diabetes.
Barriers and strategies for medication adherence in youth with type 2 diabetes were found to be similar to those observed in youth with other chronic pediatric conditions.
Identifying a patient's preferences and goals leads to a care plan that can reflect those goals, and this may improve patient satisfaction.
Long-distance air travel presents numerous unique challenges for insulin-treated patients with diabetes. More accessible and adequate sources of guidance are needed to facilitate travel planning among this patient population.
Knowing that certain characteristics increase the risk for dermatology patients who may have metabolic syndrome will enable clinicians to identify patients who may have specific cardiovascular risks.
Kevin Pantalone, DO, from the Cleveland Clinic, provides insight into the management of gastrointestinal symptoms in patients with diabetes.
Endocrinology Advisor Articles
- ADA Releases Updated Guidelines for Managing Pediatric Type 1 Diabetes
- Relationship Between HbA1c and Coronary Artery Disease
- The Obesity Paradox in Diabetes: Conceptual and Clinical Approaches
- Cost-Benefit Analysis of Insulin Analogs in Type 2 Diabetes
- Nonfunctioning Adrenal Incidentaloma Associated With Metabolic Syndrome
- Low Predictive Power of Biomarkers for Estimated Glomerular Filtration Rate Decline
- FDA to Review Gimoti for Diabetic Gastroparesis in Adult Women
- FDA Approves First Mobile App for Use in Preventing Pregnancy
- Hypothyroidism Predicts Atrial Tachyarrhythmia After AF Catheter Ablation
- Treating Painful Diabetic Peripheral Neuropathy With Electroacupuncture